Delivery Order SPE2DB24D2100-SPE2DB25FBFFT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52, with an ultimate completion date of August 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $1,385.52 under a firm fixed price arrangement, with an ultimate completion date of June 11, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $1,385.52. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 28, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. ORGOVYX...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of ORGOVYX 120 MG tablets (30-count units) with a ceiling value of $1,385.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count units of ORGOVYX 120 mg tablets with a ceiling value of $4,156.56. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This $8,313.12 firm fixed price delivery order, with a completion date of September 8, 2025, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFFTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,156.56 and an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent Indefinite Delivery Contract enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency requirements and other government healthcare systems worldwide. ORGOVYX, a prescription medication used in hormone therapy for prostate cancer treatment, represents one of the specialized pharmaceutical products the company delivers through its federal contract portfolio, which encompasses brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/15/25 |